Abstract
Recent evidence is consistent with neurotensin (NT)(8-13) adopting a Type I beta-turn conformation while binding the NT receptor, which would place the cationic side-chains of Arg(8) and Arg(9) in close proximity. This was the basis for the design, synthesis and analysis of truncated NT(9-13) analogues 1-5 with dicationic position 9 side-chains to emulate the functions of the 8 and 9 side-chains of NT(8-13).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
CHO Cells
-
Chromatography, High Pressure Liquid
-
Cricetinae
-
Humans
-
Molecular Weight
-
Neurotensin / analogs & derivatives*
-
Neurotensin / chemical synthesis
-
Neurotensin / chemistry
-
Neurotensin / pharmacology*
-
Peptide Fragments / chemical synthesis
-
Peptide Fragments / chemistry
-
Peptide Fragments / pharmacology*
-
Receptors, Neurotensin / metabolism*
-
Structure-Activity Relationship
Substances
-
Peptide Fragments
-
Receptors, Neurotensin
-
neurotensin (9-13)
-
Neurotensin